157 related items for PubMed ID: 37682369
1. Efficacy and safety of long-term repeated use of rituximab in pediatric patients with nephrotic syndrome.
Choi N, Min J, Kim JH, Kang HG, Ahn YH.
Pediatr Nephrol; 2024 Mar; 39(3):771-780. PubMed ID: 37682369
[Abstract] [Full Text] [Related]
2. Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment.
Fujinaga S, Hirano D, Mizutani A, Sakuraya K, Yamada A, Sakurai S, Shimizu T.
Clin Exp Nephrol; 2017 Aug; 21(4):671-676. PubMed ID: 27558467
[Abstract] [Full Text] [Related]
3. Immunoglobulin serum levels in rituximab-treated patients with steroid-dependent nephrotic syndrome.
Parmentier C, Delbet JD, Decramer S, Boyer O, Hogan J, Ulinski T.
Pediatr Nephrol; 2020 Mar; 35(3):455-462. PubMed ID: 31705306
[Abstract] [Full Text] [Related]
4. Late-onset adverse events after a single dose of rituximab in children with complicated steroid-dependent nephrotic syndrome.
Fujinaga S, Ozawa K, Sakuraya K, Yamada A, Shimizu T.
Clin Nephrol; 2016 Jun; 85(6):340-5. PubMed ID: 27125626
[Abstract] [Full Text] [Related]
5. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
Horinouchi T, Sako M, Nakanishi K, Ishikura K, Ito S, Nakamura H, Oba MS, Nozu K, Iijima K.
BMC Nephrol; 2018 Nov 01; 19(1):302. PubMed ID: 30382824
[Abstract] [Full Text] [Related]
6. Risk factors for relapse and long-term outcome in steroid-dependent nephrotic syndrome treated with rituximab.
Kamei K, Ogura M, Sato M, Sako M, Iijima K, Ito S.
Pediatr Nephrol; 2016 Jan 01; 31(1):89-95. PubMed ID: 26341251
[Abstract] [Full Text] [Related]
7. Predictive factors of long-term disease remission after rituximab administration in patients with childhood-onset complicated steroid-dependent nephrotic syndrome: a single-center retrospective study.
Ohyama R, Fujinaga S, Sakuraya K, Hirano D, Ito S.
Clin Exp Nephrol; 2023 Oct 01; 27(10):865-872. PubMed ID: 37477752
[Abstract] [Full Text] [Related]
8. Long-Term Efficacy and Safety of Repeated Rituximab to Maintain Remission in Idiopathic Childhood Nephrotic Syndrome: An International Study.
Chan EY, Yu ELM, Angeletti A, Arslan Z, Basu B, Boyer O, Chan CY, Colucci M, Dorval G, Dossier C, Drovandi S, Ghiggeri GM, Gipson DS, Hamada R, Hogan J, Ishikura K, Kamei K, Kemper MJ, Ma AL, Parekh RS, Radhakrishnan S, Saini P, Shen Q, Sinha R, Subun C, Teo S, Vivarelli M, Webb H, Xu H, Yap HK, Tullus K.
J Am Soc Nephrol; 2022 Jun 01; 33(6):1193-1207. PubMed ID: 35354600
[Abstract] [Full Text] [Related]
9. Periodically repeated rituximab administrations in children with refractory nephrotic syndrome: 2-year multicenter observational study.
Takahashi T, Okamoto T, Sato Y, Yamazaki T, Hayashi A, Aoyagi H, Ueno M, Kobayashi N, Uetake K, Nakanishi M, Ariga T.
Pediatr Nephrol; 2019 Jan 01; 34(1):87-96. PubMed ID: 30141179
[Abstract] [Full Text] [Related]
10. Does rituximab induce hypogammaglobulinemia in patients with pediatric idiopathic nephrotic syndrome?
Delbe-Bertin L, Aoun B, Tudorache E, Lapillone H, Ulinski T.
Pediatr Nephrol; 2013 Mar 01; 28(3):447-51. PubMed ID: 23212560
[Abstract] [Full Text] [Related]
11. Idiopathic nephrotic syndrome and rituximab: may we predict circulating B lymphocytes recovery?
Delbet JD, Leclerc G, Ulinski T.
Pediatr Nephrol; 2019 Mar 01; 34(3):529-532. PubMed ID: 30542932
[Abstract] [Full Text] [Related]
12. Rituximab in children with steroid-dependent nephrotic syndrome: experience of a tertiary center and review of the literature.
Van Horebeek I, Knops N, Van Dyck M, Levtchenko E, Mekahli D.
Acta Clin Belg; 2017 Jun 01; 72(3):147-155. PubMed ID: 27409338
[Abstract] [Full Text] [Related]
13. Effect of different rituximab regimens on B cell depletion and time to relapse in children with steroid-dependent nephrotic syndrome.
Hogan J, Dossier C, Kwon T, Macher MA, Maisin A, Couderc A, Niel O, Baudouin V, Deschênes G.
Pediatr Nephrol; 2019 Feb 01; 34(2):253-259. PubMed ID: 30109447
[Abstract] [Full Text] [Related]
14. Long-term outcomes after early treatment with rituximab for Japanese children with cyclosporine- and steroid-resistant nephrotic syndrome.
Fujinaga S, Nishino T, Umeda C, Tomii Y, Watanabe Y, Sakuraya K.
Pediatr Nephrol; 2019 Feb 01; 34(2):353-357. PubMed ID: 30426219
[Abstract] [Full Text] [Related]
15. Sequential rituximab therapy sustains remission of nephrotic syndrome but carries high risk of adverse effects.
Sinha A, Mathew G, Arushi A, Govindarajan S, Ghanapriya K, Grewal N, Rai K, Brijwal M, Kalluru SL, Tewari P, Misra A, Khandelwal P, Hari P, Bagga A.
Nephrol Dial Transplant; 2023 Mar 31; 38(4):939-949. PubMed ID: 36071552
[Abstract] [Full Text] [Related]
16. Maintenance therapy with mycophenolate mofetil after rituximab in pediatric patients with steroid-dependent nephrotic syndrome.
Ito S, Kamei K, Ogura M, Sato M, Fujimaru T, Ishikawa T, Udagawa T, Iijima K.
Pediatr Nephrol; 2011 Oct 31; 26(10):1823-8. PubMed ID: 21556716
[Abstract] [Full Text] [Related]
17. Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood--follow-up after CD19 recovery.
Sellier-Leclerc AL, Baudouin V, Kwon T, Macher MA, Guérin V, Lapillonne H, Deschênes G, Ulinski T.
Nephrol Dial Transplant; 2012 Mar 31; 27(3):1083-9. PubMed ID: 21810762
[Abstract] [Full Text] [Related]
18. Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome.
Ito S, Kamei K, Ogura M, Udagawa T, Fujinaga S, Saito M, Sako M, Iijima K.
Pediatr Nephrol; 2013 Feb 31; 28(2):257-64. PubMed ID: 23052656
[Abstract] [Full Text] [Related]
19. [Incidence of hypogammaglobulinaemia in children with steroid-dependent/frequently relapsing nephrotic syndrome treated with rituximab and its association with severe infections].
Zhi YZ, Cao L, Ying DJ, Dou WJ, Gu R, Zhang JJ.
Zhonghua Yi Xue Za Zhi; 2024 Feb 06; 104(6):433-439. PubMed ID: 38326055
[Abstract] [Full Text] [Related]
20. [Treatment of children with steroid-dependent nephrotic syndrome with rituximab].
Huang J, Du J, Wang S, Xiao L, Zhao X.
Zhonghua Er Ke Za Zhi; 2014 Jul 06; 52(7):521-4. PubMed ID: 25224058
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
